Jian-Feng Gong

Jian-Feng Gong

Auto-generated profile, based on publicly available information

Jian-Feng Gong

Research Institute of General Surgery, Jinling Hospital, Medical school of Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, Jiangsu Province, China.

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2013 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
QCQiyi Chen
Qiyi Chen
WYWenkui Yu
Wenkui Yu
JSJiangliang Shi
Jiangliang Shi
JSJuanhong Shen
Juanhong Shen
YHYimin Hu
Yimin Hu
NLNing Li
Ning Li
Background: Extra-Corporeal Membrane Oxygenation (ECMO) therapy is associated with high risk of neurologic injury. But the mechanism of neurologic injury during and/or after ECMO therapy is still unclear. Recent animal experiments confirmed that ECMO treatment increases the immune inflammatory response. The aim of this study is to investigate the effect of VV- ECMO on immune inflammatory response of cerebral tissues and neurological impairment.Methods: 18 porcine were randomly divided into control, sham and ECMO group (n = 6/group). ECMO was run 24 h in the ECMO group, and serum collected at 0, 2, 6, 12 and 24 h during ECMO treatment for the analysis of cytokine (IL-1β, IL-6, IL-10, TNF-a) and cerebral injury specific biomarker S100B and NSE. After 24 h ECMO treatment, all animals were euthanized and cerebral tissues (hypothalamus, hippocampus and cortex) were collected for measure of mRNA and protein levels of cytokine (IL-1β, IL-6, IL-10, TNF-a).Results: The results during ECMO treatment showed that all the pro-inflammation cytokines were increased significantly after 2 h, and anti-inflammation IL-10 showed transient hoist in the first 2 h in serum. After 24 h ECMO therapy, the mRNA levels of pro-inflammation cytokines and anti-inflammation IL-10 were simultaneously up-regulated in cerebral tissues (hypothalamus, hippocampus and cortex). And protein concentrations also showed different increasing levels in cerebral tissues. However, during the ECMO treatment, S100B and NSE protein in serum did not change significantly.Conclusion: These findings suggest VV-ECMO treatment can not only lead to immune inflammatory response in blood, but can also produce immune and inflammatory response in cerebral tissues. However the extent of immune inflammation was not sufficient to cause significant neurological impairment in this study. But the correlation between cerebral inflammatory response and cerebral impairment need to further explore.

15 February 2015 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
LNLing Ni
Ling Ni
QCQiyi Chen
Qiyi Chen
KZKe Zhu
Ke Zhu
JSJialiang Shi
Jialiang Shi
JSJuanhong Shen
Juanhong Shen
NLNing Li
Ning Li
It is unclear at present whether extracorporeal membrane oxygenation (ECMO) therapy can improve intestinal mucous barrier function through increased perfusion. The present study establishes an animal model for post-traumatic acute respiratory distress syndrome (ARDS) and evaluates the effect of v-vECMO treatment on the intestinal mucosal barrier. Pulmonary contusion combined with ischemia-reperfusion injury was induced in 30 piglets. The animals were randomly divided into control, model, and ECMO groups. Serum I-FABP, d-lactate, and endotoxin were measured over a 24-h period. The jejunum and colon were collected post-mortem and evaluated histopathologically. The tissue was also examined using electron microscopy, and intestinal tight junction proteins (ZO-1 and occludin) were measured after 24 h of ECMO therapy. Mortality rate and cause of death were also recorded. The serum markers evaluating the intestinal mucosal barrier deteriorated in the model group compared to the control group (p < 0.05). At 2 h, serum I-FABP, d-lactate, and endotoxin were significantly increased in the ECMO group compared to the model group (p < 0.05). At 12 h, I-FABP and d-lactate in the ECMO group dropped to model group levels. Serum d-lactate was slightly lower in the ECMO group (p > 0.05) and serum I-FABP was significantly lower than in the model group (p < 0.05) at 24 h. Similarly, serum endotoxin was slightly lower in the ECMO group than in the model group (p > 0.05) at 24 h. After 24 h of ECMO therapy, the occludin and ZO-1 protein concentrations in jejunum and colon mucosa increased moderately compared to that in the model group (p < 0.05). Morphologic structure of the jejunum and colon did not improved significantly after ECMO therapy. Finally, we observed that ECMO therapy moderately decreased mortality (25% vs. 50%). Intestinal mucosal barrier continued to deteriorate in the model group. Although early ECMO therapy aggravates intestinal mucosal injury, the damage gradually improves later during therapy. The results show that ECMO therapy has a protective effect on the intestinal mucosal barrier in the later treatment stage.

1 February 2013
Verified
Journal Article
Closed access
YLYi Li
Yi Li
NLNing Li
Ning Li
WZWei-Ming Zhu
Wei-Ming Zhu
JGJian-Feng Gong
Jian-Feng Gong
WZWei Zhang
Wei Zhang
JLJie-Shou Li
Jie-Shou Li

25 December 2016
Verified
Journal Article
Closed access
XGXiaolong Ge
Xiaolong Ge
CDChao Ding
Chao Ding
JGJianfeng Gong
Jianfeng Gong
HTHongliang Tian
Hongliang Tian
YWYao Wei
Yao Wei
NLNing Li
Ning Li

1 January 2009
Verified
Journal Article
Closed access
JGJian-Feng Gong
Jian-Feng Gong
WZWei-Ming Zhu
Wei-Ming Zhu
WYWen-Kui Yu
Wen-Kui Yu
NLNing Li
Ning Li
JLJie-Shou Li
Jie-Shou Li

1 August 2012
Verified
Journal Article
Closed access
LZLugen Zuo
Lugen Zuo
YLYi Li
Yi Li
Hong-Gang WangHong-Gang Wang
Hong-Gang Wang
WZWei-Ming Zhu
Wei-Ming Zhu
LCLei Cao
Lei Cao
JLJie-Shou Li
Jie-Shou Li